A series of in vitro and in vivo functional assays with overexpression or knockdown of SCRN2 demonstrated that SCRN2 inhibited TNBC cell proliferation, migration and invasion in vitro, and impeded xenograft tumor growth and lung metastasis in mice (Figures 3 and 5). Here, SCRN2 is linked to neoplasm.